Sharechat Logo

InvoCare's Bledisloe unit seeks clearance to expand in NZ by buying Christchurch crematoriums

Monday 5th May 2014

Text too small?

Bledisloe New Zealand, the local funeral services arm of Australia's largest undertakers InvoCare, has sought antitrust clearance to buy the 70-year-old Cremation Society of Canterbury adding two crematoriums to its New Zealand network.

Auckland-based Bledisloe is seeking Commerce Commission approval to buy the company that owns Harewood Memorial Gardens & Crematorium and Woodlawn Memorial Gardens and Crematorium in Christchurch. Bledisloe already owns three Christchurch funeral parlours and a headstone maker although it has no capacity to cremate bodies in the city, the government regulator said in a statement.

ASX-listed InvoCare set up its New Zealand subsidiary in 2007 and bought Bledisloe in 2010 for an enterprise value of A$114 million. The group has been expanding its New Zealand holdings, acquiring four funeral parlours last year, bringing its total to 29 businesses across the country.

In 2013 New Zealand sales were A$32 million with a 19 percent margin although the company estimated a 1.9 percent decline in deaths during 2013, according to InvoCare's annual report. The Cremation Society is ultimately owned by a group of Christchurch-based investors, according to the Companies Office.

The Commerce Commission decision is due Friday, May 16.

 

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors